T1	Disease 2282 2299	Alzheimer disease
T2	Disease 2301 2303	AD
*	Equiv T1 T2
T3	NumberOfFractions 950 952	72
T4	FactorValue 7953 7955	AD
T5	FactorValue 7965 7987	neurologically healthy
T6	OrganismPart 337 351	perforant path
T7	OrganismPart 645 658	dentate gyrus
T8	Instrument 15151 15189	hybrid Q-Exactive-HF mass spectrometer
T9	FragmentationMethod 15390 15426	higher energy collision dissociation
T10	CollisionEnergy 15430 15436	30-40%
T11	PrecursorMassTolerance 16333 16339	10 ppm
T12	NumberOfMissedCleavages 16481 16482	2
T13	CleavageAgent 13114 13119	Lys-C
T14	CleavageAgent 13190 13197	trypsin
T15	Label 13491 13510	TMT10plex 126-131Da
T16	FragmentMassTolerance 16372 16379	0.02 Da
T17	FractionationMethod 13924 13930	HiRIEF
T18	AlkylationReagent 12977 12992	chloroacetamide
T19	AcquisitionMethod 15322 15336	data-dependent
T20	Separation 14342 14375	UltiMate(TM) 3000 RSLCnano System
T21	Modification 16526 16554	TMT10plex on lysine residues
A1	Modification T21 fixed
T22	Modification 16526 16538;16559 16576	TMT10plex on peptide N termini
A2	Modification T22 fixed
T23	Modification 16582 16623	carbamidomethylation on cysteine residues
A3	Modification T23 fixed
T24	Modification 16662 16694	oxidation on methionine residues
A4	Modification T24 variable
T25	Organism 16196 16201	human
T26	NumberOfBiologicalReplicates 7948 7952	five
T27	NumberOfBiologicalReplicates 7960 7964	five
T28	NumberOfBiologicalReplicates 8157 8161	five
T29	NumberOfBiologicalReplicates 8169 8174	seven
T30	NumberOfTechnicalReplicates 8625 8627	No
